The law will cover medications currently in development and not yet authorised, authorised medications covered by patents as well as authorised products that are not covered by intellectual property rights.
Lai noteiktu izpētes prioritātes, regula paredz, ka divu līdz trīs gadu laikā ES ieviesīs sarakstu ar īpašajām vajadzībām pediatrijas jomā.